Journal article

PRELIMINARY SAFETY DATA FROM PATIENTS (PTS) WITH RELAPSED/REFRACTORY (R/R) B‐CELL MALIGNANCIES TREATED WITH THE NOVEL B‐CELL LYMPHOMA 2 (BCL2) INHIBITOR BGB‐11417

CY Cheah, E Verner, CS Tam, J Hilger, Y Gao, J Huang, D Simpson, S Opat

Hematological Oncology | Wiley | Published : 2021